[Computer-assisted diagnosis of rare diseases]

T Müller1, A Jerrentrup2, J R Schäfer2

  • 1Zentrum für unerkannte und seltene Erkrankungen (ZusE), Universitätsklinikum Gießen und Marburg (UKGM), Baldingerstr. 1, 35043, Marburg, Deutschland. tobias.mueller@uk-gm.de.

Der Internist
|April 2, 2017
PubMed

Insights

Diagnosing rare diseases is challenging due to their variability. Diagnostic decision-support systems like FindZebra and Phenomizer show promise for improving rare disease diagnosis and reducing misdiagnosis rates.

Area of Science:

  • Medical Informatics
  • Rare Disease Diagnosis

Background:

  • Establishing a comprehensive diagnosis is a primary challenge in clinical practice.
  • Rare diseases, numbering around 8000, present significant diagnostic hurdles due to clinical variability.
  • Clinician awareness of all rare disease entities is impossible and inefficient.

Purpose of the Study:

  • To evaluate specific diagnostic decision-support systems for rare diseases.
  • To compare the advantages and limitations of systems like FindZebra, Phenomizer, Orphanet, and Isabel.
  • To explore the potential of social media and big data in rare disease diagnostics.

Main Methods:

  • Concise presentation of four diagnostic decision-support systems: FindZebra, Phenomizer, Orphanet, and Isabel.
  • Analysis of system advantages and limitations in the context of rare disease diagnosis.
  • Review of emerging technologies like social media and big data for diagnostic support.

Main Results:

  • Specific diagnostic decision-support systems outperform standard search engines for rare diseases.
  • These tools offer a more efficient approach compared to manual memorization of rare disease information.
  • The evaluated systems present distinct benefits and drawbacks for clinical application.

Conclusions:

  • Diagnostic decision-support systems hold promise for improving the accuracy and efficiency of rare disease diagnosis.
  • These tools can potentially reduce initial misdiagnoses and shorten the time to a confirmed diagnosis.
  • Future integration of social media and big data may further enhance diagnostic capabilities for rare diseases.